The Board of Directors of the Company in its meeting held on Thursday, 29th May, 2025 has considered and approved the following business:- 1. Audited Standalone and Consolidated Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
TCM Limited's board approved audited standalone and consolidated financial results for Q4 and FY ended 31 March 2025. Standalone revenue from operations fell to ₹2,472.74 lakhs from ₹3,164.73 lakhs a year ago (down ~22%), but standalone profit after tax jumped to ₹314.92 lakhs from ₹20.36 lakhs, largely driven by a one-time write-back of ₹420.77 lakhs from a settled real estate developer advance. Consolidated revenue dropped to ₹2,600.61 lakhs and the company swung to a consolidated PAT of ₹139.93 lakhs versus a loss of ₹228.92 lakhs previously. The company also appointed new secretarial auditor (JKM Associates) and internal auditor (Jomy Saimon and Associates) for FY 2025-26. Auditor SGM & Associates gave an unmodified (clean) opinion on both sets of results.
The headline PAT jump looks strong but is largely propped up by a non-recurring developer settlement write-back rather than core operations. Underlying revenue is shrinking and operating cash flow was negative at ~₹(1,078) lakhs standalone, with short-term borrowings spiking from ₹16.63 to ₹1,115.90 lakhs. Shareholders should treat the profit growth as one-time and watch core business recovery.